Chandigarh-based finished-dosage formulation maker exporting branded generics and CMO products to 85+ countries.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 60 | 60 | 60 | 59 | 59 | 69 | 82 | 87 |
| Reserves | 544 | 541 | 622 | 872 | 952 | 1.1k | 1.2k | 1.3k |
| Borrowings | 1.0k | 953 | 862 | 17 | 16 | 41 | 22 | 18 |
| Other Liabilities | 210 | 247 | 280 | 217 | 160 | 224 | 215 | 271 |
| Total Liabilities | 1.8k | 1.8k | 1.8k | 1.2k | 1.2k | 1.4k | 1.5k | 1.7k |
| AssetsFixed Assets | 753 | 630 | 587 | 8 | 7 | 273 | 285 | 306 |
| CWIP | 19 | 10 | 8 | 0 | 0 | 0 | 0 | 10 |
| Investments | 36 | 29 | 30 | 111 | 192 | 213 | 312 | 248 |
| Other Assets | 1.0k | 1.1k | 1.2k | 1.0k | 989 | 952 | 947 | 1.1k |
| Total Assets | 1.8k | 1.8k | 1.8k | 1.2k | 1.2k | 1.4k | 1.5k | 1.7k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | -64 | 125 | 135 | 150 | 195 | -163 | -25 | -70 |
| Cash from Investing | -12 | -9 | -10 | 5 | -13 | -104 | -110 | -73 |
| Cash from Financing | 100 | -133 | -124 | -141 | -186 | 699 | 69 | 142 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -79 | 114 | 131 | 137 | 182 | -205 | -51 | -156 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
INDSWFTLAB · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.